a total of 2,880 maximum expiratory flow-volume curves were performed in a controlled double-blind cross-over examination designed to evaluate the bronchodilating effects of two different nebulized doses of salbutamol ( 1.75 and 0.875 mg ) and ipratropium bromide ( 0.175 and 0.0875 mg ) inhaled by 8 normal , 8 asthmatic , and 8 bronchitic subjects .
C0001927
salbutamol
C0004096
asthmatic